HighGravityDataCurrent guidance
107 items
UnitedHealth Group
Guidance from UnitedHealth Group’s last 8 earnings releases. Every value links to its sentence in the filing. See something wrong? Tell us.
Releases tracked
8
Latest release
Oct 13, 2026
Data checked
Oct 13, 2026
What changed in the Oct 13, 2026 release
Each item compared with the same item in the previous release (Jul 16, 2026). Values in quotation marks are the company’s words.
New — first stated in this releaseRaised / Lowered / Narrowed / Widened — changed from the prior releaseRevised — wording changed, direction not determinableChanged — value changed; the comparison couldn’t be parsed to a directionReiterated — restated unchangedNot restated — stated before, absent nowRaised and lowered describe the number, not whether the change is favorable.
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Raised | Adjusted diluted earnings per share | for FY2026 | “> $18.25” | “At least $20.50” | Filing ↗ |
| Raised | Adjusted net earnings attributable to UnitedHealth Group common shareholders | for FY2026 | “> $16,610” | “> $18,585” | Filing ↗ |
| Raised | Diluted earnings per share | for FY2026 | “> $17.35” | “At least $19.50” | Filing ↗ |
| New | Earnings Outlook (net earnings per share) | for FY2026 | — | “At Least $19.50 Per Share” | Filing ↗ |
| Raised | Net earnings attributable to UnitedHealth Group common shareholders | for FY2026 | “> $15,800” | “> $17,650” | Filing ↗ |
| Reiterated | Long-term debt-to-capital ratio target | for the long term | “approximately 40.0%” | “approximately 40.0%” | Filing ↗ |
Show 78 items not restated in this release
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Not restated | Eliminations - Revenue | for FY2026 | “~($153,500)” | — | Filing ↗ |
| Not restated | Eliminations Revenues | for FY2026 | “~$(5,000)” | — | Filing ↗ |
| Not restated | Optum - Revenue | for FY2026 | “> $257,500” | — | Filing ↗ |
| Not restated | Optum Eliminations Revenue | for FY2026 | “~$(5,000)” | — | Filing ↗ |
| Not restated | Optum Health (1) Revenues | for FY2026 | “> $91,000” | — | Filing ↗ |
| Not restated | Optum Insight Revenues | for FY2026 | “> $21,000” | — | Filing ↗ |
| Not restated | Optum revenues | for FY2026 | “more than $257.5 billion” | — | Filing ↗ |
| Not restated | Optum Rx Revenues | for FY2026 | “> $150,500” | — | Filing ↗ |
| Not restated | Revenue outlook | for FY2026 | “Greater Than $439.0 Billion” | — | Filing ↗ |
| Not restated | Revenue year-over-year change | for FY2026 | “a 2% year-over-year decline” | — | Filing ↗ |
| Not restated | Total Optum Revenues | for FY2026 | “> $257,500” | — | Filing ↗ |
| Not restated | Total UnitedHealth Group - Revenue | for FY2026 | “> $439,000” | — | Filing ↗ |
| Not restated | Total UnitedHealthcare Revenue | for FY2026 | “> $335,000” | — | Filing ↗ |
| Not restated | UnitedHealthcare Community & State Revenue | for FY2026 | “> $95,000” | — | Filing ↗ |
| Not restated | UnitedHealthcare Employer & Individual Revenue | for FY2026 | “> $75,000” | — | Filing ↗ |
| Not restated | UnitedHealthcare revenues | for FY2026 | “more than $335.0 billion” | — | Filing ↗ |
| Not restated | Adjusted Earnings per Share (1) | for FY2026 | “> $17.75” | — | Filing ↗ |
| Not restated | Adjusted Operating Earnings - Optum Health | for FY2026 | “> $1,577” | — | Filing ↗ |
| Not restated | Adjusted Operating Earnings - Total Optum | for FY2026 | “> $12,577” | — | Filing ↗ |
| Not restated | Diluted Net Earnings per Share to UNH Shareholders | for FY2026 | “$18.45 - $18.95” | — | Filing ↗ |
| Not restated | Earnings from operations | for FY2026 | “Greater Than $24.0 Billion” | — | Filing ↗ |
| Not restated | Earnings outlook | for FY2026 | “Greater Than $17.35 Per Share” | — | Filing ↗ |
| Not restated | Earnings Outlook (Diluted EPS) | for FY2026 | “$18.45 to $18.95 Per Share” | — | Filing ↗ |
| Not restated | Net Earnings to UNH Shareholders | for FY2026 | “> $16,750” | — | Filing ↗ |
| Not restated | Operating Earnings - Optum | for FY2026 | “> $13,200” | — | Filing ↗ |
| Not restated | Operating Earnings - Optum Health | for FY2026 | “> $2,200” | — | Filing ↗ |
| Not restated | Operating Earnings - UnitedHealth Group | for FY2026 | “> $24,000” | — | Filing ↗ |
| Not restated | Operating Earnings - UnitedHealthcare | for FY2026 | “> $10,800” | — | Filing ↗ |
| Not restated | Optum (a) - Adjusted Operating Earnings | for FY2026 | “> $13,215” | — | Filing ↗ |
| Not restated | Optum (a) - Reported Operating Earnings | for FY2026 | “> $13,450” | — | Filing ↗ |
| Not restated | Optum earnings from operations | for FY2026 | “greater than $13.2 billion” | — | Filing ↗ |
| Not restated | Optum Health - Adjusted Operating Earnings | for FY2026 | “> $2,215” | — | Filing ↗ |
| Not restated | Optum Health - Reported Operating Earnings | for FY2026 | “> $2,275” | — | Filing ↗ |
| Not restated | Optum Health (1) Operating Earnings | for FY2026 | “> $2,200” | — | Filing ↗ |
| Not restated | Optum Health (1) Operating Margin | for FY2026 | “~2.4%” | — | Filing ↗ |
| Not restated | Optum Insight - Adjusted Operating Earnings | for FY2026 | “> $4,750” | — | Filing ↗ |
| Not restated | Optum Insight - Reported Operating Earnings | for FY2026 | “> $4,925” | — | Filing ↗ |
| Not restated | Optum Insight Operating Earnings | for FY2026 | “> $4,750” | — | Filing ↗ |
| Not restated | Optum Rx - Reported Operating Earnings | for FY2026 | “> $6,250” | — | Filing ↗ |
| Not restated | Optum Rx Operating Earnings | for FY2026 | “> $6,250” | — | Filing ↗ |
| Not restated | Optum Rx Operating Margin | for FY2026 | “~4.2%” | — | Filing ↗ |
| Not restated | Return to earnings growth | for FY2026 | “return to earnings growth” | — | Filing ↗ |
| Not restated | Total Optum Operating Earnings | for FY2026 | “> $13,200” | — | Filing ↗ |
| Not restated | Total UnitedHealth Group - Operating Earnings | for FY2026 | “> $24,000” | — | Filing ↗ |
| Not restated | UnitedHealth Group - Adjusted Operating Earnings | for FY2026 | “> $25,215” | — | Filing ↗ |
| Not restated | UnitedHealth Group - Reported Operating Earnings | for FY2026 | “> $25,450” | — | Filing ↗ |
| Not restated | UnitedHealthcare - Operating Earnings | for FY2026 | “> $10,800” | — | Filing ↗ |
| Not restated | UnitedHealthcare - Reported Operating Earnings | for FY2026 | “> $12,000” | — | Filing ↗ |
| Not restated | UnitedHealthcare earnings from operations | for FY2026 | “greater than $10.8 billion” | — | Filing ↗ |
| Not restated | Doula care coverage eligible members | for FY2027 | “more than 7 million” | — | Filing ↗ |
| Not restated | Capital Expenditures | for FY2026 | “~$3,800” | — | Filing ↗ |
| Not restated | Cash Flows from Operations | for FY2026 | “> $18,000” | — | Filing ↗ |
| Not restated | Commercial Fee - Growth (Contraction) in People Served | for FY2026 | “550 – 750” | — | Filing ↗ |
| Not restated | Commercial Fee - Total People Served | for FY2026 | “22,035 – 22,235” | — | Filing ↗ |
| Not restated | Commercial Risk - Growth (Contraction) in People Served | for FY2026 | “(1,400) – (1,300)” | — | Filing ↗ |
| Not restated | Commercial Risk - Total People Served | for FY2026 | “6,765 – 6,865” | — | Filing ↗ |
| Not restated | Contraction in people served through Medicare Advantage | for FY2026 | “(1,400,000) to (1,300,000)” | — | Filing ↗ |
| Not restated | Diluted Weighted-Average Shares | for FY2026 | “910 – 915” | — | Filing ↗ |
| Not restated | Dividends Paid (at current rate) | for FY2026 | “~$8,000” | — | Filing ↗ |
| Not restated | Interest Expense | for FY2026 | “~$3,700” | — | Filing ↗ |
| Not restated | Investment and Other Income | for FY2026 | “~$3,900” | — | Filing ↗ |
| Not restated | Medicaid - Growth (Contraction) in People Served | for FY2026 | “(715) – (565)” | — | Filing ↗ |
| Not restated | Medicaid - Total People Served | for FY2026 | “6,665 – 6,815” | — | Filing ↗ |
| Not restated | Medicare Advantage - Total People Served | for FY2026 | “7,245 – 7,295” | — | Filing ↗ |
| Not restated | Medicare Advantage People Served Growth (Contraction) | for FY2026 | “(1,200) – (1,150)” | — | Filing ↗ |
| Not restated | Optum Health Consumers Served | for FY2026 | “~84 million” | — | Filing ↗ |
| Not restated | Optum Health Fully Accountable Patients | for FY2026 | “~4.1 million” | — | Filing ↗ |
| Not restated | Optum Rx Adjusted Scripts | for FY2026 | “> 1.52 billion” | — | Filing ↗ |
| Not restated | Pediatric prior approval requirement elimination | for FY2026 | “nearly two-thirds” | — | Filing ↗ |
| Not restated | Projected 2026 expected reduction of loss contracts reserves | for FY2026 | “$402 million” | — | Filing ↗ |
| Not restated | Stand-Alone Part D Prescription Drug Plans - Total People Served | for FY2026 | “2,570 – 2,670” | — | Filing ↗ |
| Not restated | Standardized Medicare Supplement - Growth (Contraction) in People Served | for FY2026 | “(50) – 0” | — | Filing ↗ |
| Not restated | Tax Rate | for FY2026 | “~19.25%” | — | Filing ↗ |
| Not restated | Total Commercial - Growth (Contraction) in People Served | for FY2026 | “(850) – (550)” | — | Filing ↗ |
| Not restated | Total Commercial - Total People Served | for FY2026 | “28,800 – 29,100” | — | Filing ↗ |
| Not restated | Total Medical - Growth (Contraction) in People Served | for FY2026 | “(2,815) – (2,265)” | — | Filing ↗ |
| Not restated | Total Medical - Total People Served | for FY2026 | “46,945 – 47,495” | — | Filing ↗ |
| Not restated | UnitedHealthcare membership | for FY2026 | “range between 46.9 million to 47.5 million” | — | Filing ↗ |
Current guidance
Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.
Current fiscal year
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Eliminations - Revenue | “~($153,500)” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Eliminations Revenues | “~$(5,000)” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum - Revenue | “> $257,500” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Eliminations Revenue | “~$(5,000)” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Health (1) Revenues | “> $91,000” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Insight Revenues | “> $21,000” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum revenues | “more than $257.5 billion” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Rx Revenues | “> $150,500” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Revenue outlook | “Greater Than $439.0 Billion” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Revenue year-over-year change | “a 2% year-over-year decline” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Total Optum Revenues | “> $257,500” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Total UnitedHealth Group - Revenue | “> $439,000” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Total UnitedHealthcare Revenue | “> $335,000” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare Community & State Revenue | “> $95,000” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare Employer & Individual Revenue | “> $75,000” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare Medicare & Retirement Revenue | “> $165,000” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare revenues | “more than $335.0 billion” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Adjusted diluted earnings per share | “At least $20.50” | for FY2026 | Company-defined | Apr 21, 2026 | 2 | Filing ↗ |
| Adjusted earnings outlook | “$19.50 to $20.00 Per Share” | for FY2026 | Company-defined | Apr 21, 2026 | 2 | Filing ↗ |
| Adjusted Earnings per Share (1) | “> $17.75” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Adjusted net earnings attributable to UnitedHealth Group common shareholders | “> $18,585” | for FY2026 | Company-defined | Apr 21, 2026 | 2 | Filing ↗ |
| Adjusted Net Earnings per Share (b) | “$19.50 - $20.00” | for FY2026 | Company-defined | Jan 27, 2026 | 2 | Filing ↗ |
| Adjusted Operating Earnings - Optum Health | “> $1,577” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Adjusted Operating Earnings - Total Optum | “> $12,577” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Adjusted Operating Earnings Margin - Optum Health | “~1.7%” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Alegeus Technologies acquisition earnings impact | “earnings neutral to 2026” | for FY2026 | Company-defined | Apr 21, 2026 | 1 | Filing ↗ |
| Diluted earnings per share | “At least $19.50” | for FY2026 | GAAP-tied | Apr 21, 2026 | 2 | Filing ↗ |
| Diluted Net Earnings per Share to UNH Shareholders | “$18.45 - $18.95” | for FY2026 | GAAP-tied | Jan 27, 2026 | 2 | Filing ↗ |
| Earnings from operations | “Greater Than $24.0 Billion” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Earnings outlook | “Greater Than $17.35 Per Share” | for FY2026 | Company-defined | Apr 21, 2026 | 1 | Filing ↗ |
| Earnings Outlook (Diluted EPS) | “$18.45 to $18.95 Per Share” | for FY2026 | GAAP-tied | Jul 16, 2026 | 1 | Filing ↗ |
| Earnings Outlook (net earnings per share) | “At Least $19.50 Per Share” | for FY2026 | GAAP-tied | Oct 13, 2026 | 1 | Filing ↗ |
| Net earnings attributable to UnitedHealth Group common shareholders | “> $17,650” | for FY2026 | GAAP-tied | Apr 21, 2026 | 2 | Filing ↗ |
| Net Earnings to UNH Shareholders | “> $16,750” | for FY2026 | GAAP-tied | Jan 27, 2026 | 2 | Filing ↗ |
| Net margin | “~3.6%” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Operating Earnings - Optum | “> $13,200” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Operating Earnings - Optum Health | “> $2,200” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Operating Earnings - UnitedHealth Group | “> $24,000” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Operating Earnings - UnitedHealthcare | “> $10,800” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Operating margin | “5.5%” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum (a) - Adjusted Operating Earnings | “> $13,215” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Optum (a) - Reported Operating Earnings | “> $13,450” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Optum adjusted operating earnings margin excluding loss contracts impact | “~4.9%” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum earnings from operations | “greater than $13.2 billion” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Health - Adjusted Operating Earnings | “> $2,215” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Optum Health - Reported Operating Earnings | “> $2,275” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Optum Health (1) Operating Earnings | “> $2,200” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Health (1) Operating Margin | “~2.4%” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Insight - Adjusted Operating Earnings | “> $4,750” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Optum Insight - Reported Operating Earnings | “> $4,925” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Optum Insight Operating Earnings | “> $4,750” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Insight Operating Margin | “~22.6%” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Rx - Reported Operating Earnings | “> $6,250” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Optum Rx Operating Earnings | “> $6,250” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Rx Operating Margin | “~4.2%” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Return to earnings growth | “return to earnings growth” | for FY2026 | Company-defined | Jul 29, 2025 | 1 | Filing ↗ |
| Total Optum Operating Earnings | “> $13,200” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Total Optum Operating Margin | “~5.1%” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Total UnitedHealth Group - Operating Earnings | “> $24,000” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealth Group - Adjusted Operating Earnings | “> $25,215” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| UnitedHealth Group - Reported Operating Earnings | “> $25,450” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| UnitedHealthcare - Operating Earnings | “> $10,800” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare - Reported Operating Earnings | “> $12,000” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| UnitedHealthcare earnings from operations | “greater than $10.8 billion” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare Operating Margin | “~3.2%” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Capital Expenditures | “~$3,800” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Cash Flows from Operations | “> $18,000” | for FY2026 | Company-defined | Jan 27, 2026 | 2 | Filing ↗ |
| Commercial Fee - Growth (Contraction) in People Served | “550 – 750” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Commercial Fee - Total People Served | “22,035 – 22,235” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Commercial Risk - Growth (Contraction) in People Served | “(1,400) – (1,300)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Commercial Risk - Total People Served | “6,765 – 6,865” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Contraction in people served through Medicare Advantage | “(1,400,000) to (1,300,000)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Depreciation and Amortization | “~$4,400” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Diluted Weighted-Average Shares | “910 – 915” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Dividends Paid (at current rate) | “~$8,000” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Interest Expense | “~$3,700” | for FY2026 | GAAP-tied | Jan 27, 2026 | 1 | Filing ↗ |
| Investment and Other Income | “~$3,900” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Medicaid - Growth (Contraction) in People Served | “(715) – (565)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Medicaid - Total People Served | “6,665 – 6,815” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Medical Care Ratio | “88.1% ± 25 bps” | for FY2026 | Company-defined | Jan 27, 2026 | 2 | Filing ↗ |
| Medicare Advantage - Growth (Contraction) in People Served | “(1,200) – (1,150) (1)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Medicare Advantage - Total People Served | “7,245 – 7,295” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Medicare Advantage medical cost trend acceleration expectation | “nearly 10%” | for FY2026 | Company-defined | Jul 29, 2025 | 1 | Filing ↗ |
| Medicare Advantage People Served Growth (Contraction) | “(1,200) – (1,150)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Operating Cost Ratio | “12.8% ± 50 bps” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Health Consumers Served | “~84 million” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Health Fully Accountable Patients | “~4.1 million” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Optum Rx Adjusted Scripts | “> 1.52 billion” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Pediatric prior approval requirement elimination | “nearly two-thirds” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Prior approval volume elimination | “30%” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
| Projected 2026 expected reduction of loss contracts reserves | “$402 million” | for FY2026 | Company-defined | Apr 21, 2026 | 1 | Filing ↗ |
| Share Repurchase | “at least $5.0 billion” | for FY2026 | Declared action | Jan 27, 2026 | 2 | Filing ↗ |
| Stand-Alone Part D Prescription Drug Plans - Growth (Contraction) in People Served | “(200) – (100)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Stand-Alone Part D Prescription Drug Plans - Total People Served | “2,570 – 2,670” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Standardized Medicare Supplement - Growth (Contraction) in People Served | “(50) – 0” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Standardized Medicare Supplement - Total People Served | “4,235 – 4,285” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Tax Rate | “~19.25%” | for FY2026 | Company-defined | Jan 27, 2026 | 2 | Filing ↗ |
| Total Commercial - Growth (Contraction) in People Served | “(850) – (550)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Total Commercial - Total People Served | “28,800 – 29,100” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Total Medical - Growth (Contraction) in People Served | “(2,815) – (2,265)” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| Total Medical - Total People Served | “46,945 – 47,495” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare membership | “range between 46.9 million to 47.5 million” | for FY2026 | Company-defined | Jan 27, 2026 | 1 | Filing ↗ |
| UnitedHealthcare prior approvals included in electronic submission standardization | “more than 70%” | for FY2026 | Company-defined | Jul 16, 2026 | 1 | Filing ↗ |
Next year and medium term
Long term
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Long-term earnings growth rate target | “13 to 16%” | for the long term | Company-defined | Apr 17, 2025 | 1 | Filing ↗ |
| Long-term debt-to-capital ratio target | “approximately 40.0%” | for the long term | GAAP-tied | Jan 27, 2026 | 4 | Filing ↗ |
| Timing to reach long-term debt-to-capital ratio target | “expects to reach that level in the back half of 2026” | for the long term | GAAP-tied | Apr 21, 2026 | 1 | Filing ↗ |
No period stated
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Quarterly dividend rate | “$2.21” | — | Declared action | Jul 29, 2025 | 1 | Filing ↗ |
How one item moved
Net earnings attributable to UnitedHealth Group common shareholders, for FY2025 — every statement across the year, each linked to its filing.
How your Healthcare payers & distributors sector group guides
12 companies in Healthcare payers & distributors. What they guide on, and who reported this season.
Most-guided metric families
This season’s releases
| UnitedHealth Group | Oct 13, 2026 | 5 changes |
| Cardinal Health | Aug 11, 2026 | 13 changes |
| Cencora | Aug 5, 2026 | 11 changes |
| CVS Health | Aug 5, 2026 | 5 changes |
| McKesson | Aug 5, 2026 | 1 change |
| Labcorp | Jul 30, 2026 | 2 changes |
| The Cigna Group | Jul 30, 2026 | 3 changes |
| Humana | Jul 29, 2026 | 4 changes |
Get this for your own peer set — Peer Guidance Briefing, $3,000.
Full history
Every metric, every release, eight quarters — the complete record as one table.
| Metric | FY2028 | FY2027 | FY2026 | FY2025 | Long-term | No period |
|---|---|---|---|---|---|---|
| Community & State Revenues | — | — | — | 1 statement | — | — |
| Eliminations - Revenue | — | — | 2 statements | 2 statements | — | — |
| Employer & Individual Revenues | — | — | — | 1 statement | — | — |
| Medicare & Retirement Revenues | — | — | — | 1 statement | — | — |
| Optum - Revenue | — | — | 2 statements | — | — | — |
The full record for UnitedHealth Group and its Healthcare payers & distributors peers, delivered as a Peer Guidance Briefing — PDF and Excel, every value linked to its filing.
Filings
The 8 earnings releases this page is built from.
| Filed | Fiscal period | Accession | Guidance items | |
|---|---|---|---|---|
| Oct 13, 2026 | FY2026 Q3 | 0000731766-26-000255 | 6 | Open filing ↗ |
| Jul 16, 2026 | FY2026 Q2 | 0000731766-26-000191 | 30 | Open filing ↗ |
| Apr 21, 2026 | FY2026 Q1 | 0000731766-26-000121 | 12 | Open filing ↗ |
| Jan 27, 2026 | FY2025 Q4 | 0000731766-26-000025 | 74 | Open filing ↗ |
| Oct 28, 2025 | FY2025 Q3 | 0000731766-25-000301 | 8 | Open filing ↗ |
| Jul 29, 2025 | FY2025 Q2 | 0000731766-25-000228 | 77 | Open filing ↗ |
| Apr 17, 2025 | FY2025 Q1 | 0000731766-25-000123 | 5 | Open filing ↗ |
| Jan 16, 2025 | FY2024 Q4 | 0000731766-25-000022 | 7 | Open filing ↗ |
Values in quotation marks are the company’s words; the classification and filing links are HighGravityData’s. HighGravityData does not score or rank companies or give investment advice.
Report an error